One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 1, 2009, Pages 27-33

  Jaissle, Gesine B ^a   Leitritz, Martin ^a   Gelisken, Faik ^a   Ziemssen, Focke ^a   Bartz Schmidt, Karl Ulrich ^a   Szurman, Peter ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Anti VEGF therapy; Bevacizumab; Branch retinal vein occlusion; Macular edema

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ENDOPHTHALMITIS; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LASER COAGULATION; LONG TERM CARE; MALE; PRIORITY JOURNAL; REPEAT PROCEDURE; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; SYSTEMIC DISEASE; TREATMENT DURATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; VITREOUS BODY;

EID: 56949090973     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0916-2     Document Type: Article

References (18)

1. The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271-282
2. Mandelcorn MS, Nrusimhadevara RK (2004) Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: A report of 14 cases. Retina 24:348-355. doi: 10.1097/ 00006982-200406000-00002
3. Mester U, Dillinger P (2002) Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 22:740-746. doi: 10.1097/00006982-200212000-00009
4. Fekrat S, Goldberg MF, Finkelstein D (1998) Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol 116:43-52
5. Weiss JN, Bynoe LA (2001) Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 108:2249-2257. doi: 10.1016/S0161-6420(01)00875-2
6. Singh RP, Margolis R, Kaiser PK (2007) Cystoid puncture for chronic cystoid macular oedema. Br J Ophthalmol 91:1062-1064. doi: 10.1136/ bjo.2006.101790
7. Cekiç O, Chang S, Tseng JJ, Barile GR, DelPriore LV, Weissman H et al (2005) Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 25:851-855. doi: 10.1097/00006982-200510000-00006
8. Jaissle GB, Ziemssen F, Petermeier K, Szurman P, Ladewig M, Gelisken F et al (2006) Bevacizumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 103:471-475. doi: 10.1007/ s00347-006-1355-2
9. Stahl A, Agostini H, Hansen LL, Feltgen N (2007) Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch Clin Exp Ophthalmol 245:1429-1436. doi: 10.1007/s00417-007-0569-6
10. Pai SA, Shetty R, Vijayan PB, Venkatasubramaniam G, Yadav NK, Shetty BK et al (2007) Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 143:601-606. doi: 10.1016/j.ajo.2006.12.037
11. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL (2007) Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 27:419-425. doi: 10.1097/IAE.0b013e318030e77e
12. Kreutzer TC, Alge CS, Wolf AH, Kook D, Burger J, Strauss R et al (2008) Intravitreal bevacizumab for the treatment of macular edema secondary to branch retinal vein occlusion. Br J Ophthalmol 92:351-355. doi: 10.1136/ bjo.2007.123513
13. Kriechbaum K, Michels S, Prager F, Georgopoulos M, Funk M, Geitzenauer W et al (2008) Intravitreal Avastin for macular edmema secondary to retinal vein occlusion - a prospective study. Br J Ophthalmol 92:518-522. doi: 10.1136/bjo.2007.127282
14. Wu L, Arevalo JF, Roca JA, Maia M, Berrocal MH, Rodriguez FJ et al (2008) Pan-American Collaborative Retina Study Group (PACORES). Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up. Retina 28:212-219
15. Jaissle GB, Karl I, Bartz-Schmidt KU (2008) Einwilligung und Besonderheiten der Aufklärung im Off-Label-Bereich. In: Bartz-Schmidt KU, Ziemssen F (Eds) Intravitreale Pharmakotherapie. Moderne Medikamente und ihre Anwendung am Auge. Schattauer, Stuttgart, pp 25-29
16. Jaissle GB, Szurman P, Bartz-Schmidt KU, German Retina Society German Society of Ophthalmology; German Professional Association of Ophthalmologists (2005) Recommendation for the implementation of intravitreal injections-statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Klin Monatsbl Augenheilkd 222:390-395. doi: 10.1055/s-2005-858231
17. Sadda SR, Wu Z, Walsh AC, Richine L, Dougall J, Cortez R et al (2006) Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 113:285-293. doi: 10.1016/j.ophtha.2005.10.005
18. Bolz M, Ritter M, Polak K, Ahlers C, Hirn C, Prünte C et al (2008) The role of Stratus OCT in anti-VEGF therapy: Qualitative and quantitative assessment of neovascular AMD. Ophthalmologe [Epub ahead of print]